Medical Policy

Effective Date:04/06/2011 Title:Plantar Fasciitis Treatments
Revision Date:10/01/2015 Document:BI293:00
CPT Code(s):0101T, 0102T, 29893, 77401, 77402, 77407, 77412, 77417
Public Statement

Effective Date:

a)    This policy will apply to all services performed on or after the above revision date which will become the new effective date.

b)    For all services referred to in this policy that were performed before the revision date, contact customer service for the rules that would apply.

1)    Plantar fasciitis treatment by shock wave therapy is not covered.

2)    Plantar fasciitis treatment by radiofrequency ablation treatment is considered experimental/investigational and not covered.

3)    Endoscopic plantar fasciotomy is a covered service.

Medical Statement

1.    QualChoice considers endoscopic plantar fasciotomy as an alternative to conventional open plantar fasciotomy medically necessary in members with intractable plantar fasciitis or heel spur syndrome who have failed a 6-month trial of conservative therapy.

2.    QualChoice considers extracorporeal shock-wave therapy (ESWT) with the OssaTron (HealthTronics, Marietta, GA), the Dornier Epos Ultra (Dornier Medical Systems, Kennesaw, GA), the Sonocur (Siemens Medical Solutions Inc., Iselin, NJ), the Orbasone Pain Relief System (Orthometrix, Inc., White Plains, NY), the OrthospecTM Extracorporeal Shock Wave Therapy (Medispec, Ltd., Germantown, MD), or any other ESWT devices experimental and investigational for plantar fasciitis. Search for BI "Extracorporeal Shock Wave Therapy (Orthotripsy)"

3.    QualChoice considers radiofrequency lesioning, radiotherapy, marrow stimulation techniques (micro fracture, drilling), or cryosurgery (cryotherapy) experimental and investigational for members with plantar fasciitis.  There is a lack of published literature documenting the safety and efficacy of these techniques in the treatment of plantar fasciitis.  

Codes Used In This BI:

28890 High Energy Eswt Plantar Fascia (deleted 1-1-15)
0019T Extracorp Shockwave Tx Ms NOS (deleted 1-1-15)
0101T Extracorp Shockwave Tx Hi Enrg
0102T Extracorp Shockwave Tx Anesth
29893 Endoscopic plantar fasciotomy
77401 Rad trmt delivery, super/ortho voltage, per day
77402 Rad trmt del, =>1 MeV; simple
77407 Rad trmt del, =>1 MeV; intermed
77412 Rad trmt del, =>1 MeV; complex
77417 Therapeutic rad port film(s)
77403 Simple; 6-10 MeV (deleted 1-1-15)
77404 Simple; 11-19 MeV (deleted 1-1-15)
77406 Simple; 20 MeV or grtr (deleted 1-1-15)
77408 Itrmed; 6-10 MeV (deleted 1-1-15)
77409 Itrmed; 11-19 MeV (deleted 1-1-15)
77411 Itrmed; 20 MeV or grtr (deleted 1-1-15)
77413 Complex; 6-10 MeV (deleted 1-1-15)
77414 Complex; 11-19 MeV (deleted 1-1-15)
77416 Complex; 20 MeV or grtr (deleted 1-1-15)
77418 IMRT Delivery (deleted 1-1-15)
77421 Stereoscopic Imaging Guide (deleted 1-1-15)
 

Limits
Intentially left empty
Reference
  1. Barrett SL, Day SV. Endoscopic plantar fasciotomy for chronic plantar fasciitis/heel spur syndrome: Surgical technique - Early clinical results. J Foot Ankle Surg. 1991;30:568-570.  
  2. Barrett SL, Day SV. Endoscopic plantar fasciotomy: Two portal endoscopic surgical techniques - Clinical results of 65 procedures. J Foot Ankle Surg. 1993;32:248-256.  
  3. Barrett SL, Day SV, Pignetti TT, Robinson LB. Endoscopic plantar fasciotomy: A multi-surgeon prospective analysis of 652 cases. J Foot Ankle Surg. 1995;34(4):400-406.  
  4. Tomczak RL, Haverstock BD. A retrospective comparison of endoscopic plantar fasciotomy to open plantar fasciotomy with heel spur resection for chronic plantar fasciitis/heel spur syndrome. J Foot Ankle Surg. 1995;34(30):305-311. 
  5. Stone PA, McClure LP. Retrospective review of endoscopic plantar fasciotomy. 1994 through 1997. J Am Podiatr Med Assoc. 1999;89(2):89-93.  
  6. Brekke MK, Green DR. Retrospective analysis of minimal-incision, endoscopic, and open procedures for heel spur syndrome. J Am Podiatr Med Assoc. 1998;88(2):64-72.  
  7. Stone PA, Davies JL. Retrospective review of endoscopic plantar fasciotomy--1992 through 1994. J Am Podiatr Med Assoc. 1996;86(9):414-420.  
  8. Wander DS. A retrospective comparison of endoscopic plantar fasciotomy to open plantar fasciotomy with heel spur resection for chronic plantar fasciitis/heel spur syndrome. J Foot Ankle Surg. 1996;35(2):183-184.  
  9. Landsman A. Endoscopic plantar fasciotomy: A multi-surgeon prospective analysis of 652 cases. J Foot Ankle Surg. 1996;35(1):86.  
  10. Barrett SL. Endoscopic plantar fasciotomy. Clin Podiatr Med Surg. 1994;11(3):469-481.  
  11. Wander DS. Endoscopic plantar fasciotomy versus traditional heel spur surgery. J Foot Ankle Surg. 1994;33(3):322.  
  12. Kinley S, Frascone S, Calderone D, et al. Endoscopic plantar fasciotomy versus traditional heel spur surgery: A prospective study. J Foot Ankle Surg. 1993;32(6):595-603. 
  13. Basford JR, Malanga GA, Krause DA, Harmsen WS. A randomized controlled evaluation of low-intensity laser therapy: Plantar fasciitis. Arch Phys Med Rehab. 1998;79(3):249-254.  
  14. Seegenschmiedt MH, Keilholz L, and Katalinic A, et al. Heel spur: Radiation therapy for refractory pain - Results with three treatment concepts. Radiology. 1996;200(1):271-276.  
  15. Sollitto RJ, Plotkin EL, Klein PG, Mullin P. Early clinical results of the use of radiofrequency lesioning in the treatment of plantar fasciitis. J Foot Ankle Surg. 1997;36(3):215-219; discussion 256.  
  16. U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Device Evaluation and Research (CDER). PMA for HealthTronics Ossatron. Orthopedics and Rehabilitation Devices Advisory Committee Transcript. Gaithersburg, MD: FDA; July 20, 2000. Available at: http://www.fda.gov/ohrms/dockets/ac/00/transcripts/3633t1.rtf
Application to Products
This policy applies to all health plans administered by QualChoice, both those insured by QualChoice and those that are self-funded by the sponsoring employer, unless there is indication in this policy otherwise or a stated exclusion in your medical plan booklet. Consult the individual plan sponsor Summary Plan Description (SPD) for self-insured plans or the specific Evidence of Coverage (EOC) for those plans insured by QualChoice. In the event of a discrepancy between this policy and a self-insured customer’s SPD or the specific QualChoice EOC, the SPD or EOC, as applicable, will prevail. State and federal mandates will be followed as they apply.

Changes: QualChoice reserves the right to alter, amend, change or supplement benefit interpretations as needed.